EODData

FRA, PHPN: Galectin Therapeutics Inc

14 Aug 2026
LAST:

2.800

CHANGE:
 0.10
OPEN:
3.020
HIGH:
3.020
ASK:
0.000
VOLUME:
0
CHG(%):
3.70
PREV:
2.700
LOW:
2.800
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
14 Aug 263.0203.0202.8002.8000
13 Aug 262.7002.7002.7002.7000
12 Aug 262.6802.6802.6802.6800
07 Aug 262.7602.7602.7602.7600
06 Aug 262.6602.6602.6602.6600
04 Aug 262.6002.6002.4402.4400
03 Aug 262.5602.5602.5602.5600
31 Jul 262.7802.7802.4602.4600
30 Jul 263.0203.0203.0203.0200
29 Jul 262.9402.9402.9402.9400

PROFILE

Name:Galectin Therapeutics Inc
About:Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Sector:Healthcare
Industry:Biotechnology
Address:4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
Website:https://galectintherapeutics.com
ISIN:US3632252025
LEI:5299004HFYSAZM2ALW85

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-7.08 
Forward P/E:-5.57 
PEG Ratio:0.15 
Price to Book:-1.72 
Return on Assets:-0.80 
Return on Equity:0.25 
Shares:64.06M 
Market Cap:179.37M 

TECHNICAL INDICATORS

MA5:2.722.9%
MA10:2.703.6%
MA20:3.079.5%
MA50:2.893.3%
MA100:2.4514.3%
MA200:3.007.1%
STO9:62.07
STO14:62.07
RSI14:36.46 
WPR14:-37.93
MTM14:-0.22
ROC14:-0.07 
ATR:0.16 
Week High:3.027.9%
Week Low:2.684.5%
Month High:4.6265.0%
Month Low:2.447.1%
Year High:5.80107.1%
Year Low:1.6173.9%
Volatility:30.28 

RECENT SPLITS

Date Ratio
23 Mar 20121-6